Synthesis and stability of oxetane analogs of thalidomide and lenalidomide

Organic Letters

Volumn 15, Issue 17, 2013, Pages 4312-4315

  Burkhard, Johannes A ^a   Wuitschik, Georg ^b   Plancher, Jean Marc ^b   Rogers Evans, Mark ^b   Carreira, Erick M ^a  

^a ETH ZURICH   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; ETHER DERIVATIVE; LENALIDOMIDE; OXETANE; THALIDOMIDE;

ANIMAL; ARTICLE; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; HUMAN; LIVER CELL; LIVER MICROSOME; METABOLISM; MOUSE; RAT; SYNTHESIS;

ANIMALS; DRUG DISCOVERY; ETHERS, CYCLIC; HEPATOCYTES; HUMANS; MICE; MICROSOMES, LIVER; MOLECULAR STRUCTURE; RATS; THALIDOMIDE;

EID: 84883796483     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol401705a     Document Type: Article

References (22)

1. Matthews, S. J.; McCoy, C. Clin. Ther. 2003, 25, 342
2. Sheskin, J. Clin. Pharmacol. Ther. 1965, 6, 303
3. Chen, M.; Doherty, S. D.; Hsu, S. Dermatol. Clin. 2010, 3, 577
4. Ito, T. Science 2010, 327, 1345
5. D'Amato, R. J.; Loughnan, M. S.; Flynn, E.; Folkman, J. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 4082
6. Bauer, K. S.; Dixon, S. C.; Figg, W. D. Biochem. Pharmacol. 1998, 55, 1827
7. Lepper, E. R.; Smith, N. F.; Cox, M. C.; Scripture, C. D.; Figg, W. D. Curr. Drug Metab. 2006, 7, 677
8. Kumar, N.; Sharma, U.; Singh, C.; Singh, B. Curr. Top. Med. Chem. 2012, 12, 1436
9. Oxetanes have been shown to have increased metabolic stability relative to other cyclic ethers: Stepan, A. F.; Karki, K.; McDonald, W. S.; Dorff, P. H.; Dutra, J. K.; DiRico, K. J.; Won, A.; Subramanyam, C.; Efremov, I. V.; O'Donnell, C. J.; Nolan, C. E.; Becker, S. L.; Pustilnik, L. R.; Sneed, B.; Sun, H.; Lu, Y.; Robshaw, A. E.; Riddell, D.; O'Sullivan, T. J.; Sibley, E.; Capetta, S.; Atchison, K.; Hallgren, A. J.; Miller, E.; Wood, A.; Obach, R. S. J. Med. Chem. 2011, 54, 7772
10. Prepared according to: Simoni, D.; Rondanin, R.; Morini, M.; Baruchello, R.; Invidiata, F. P. Tetrahedron Lett. 2000, 41, 1607
11. Burkhard, J. A.; Tchitchanov, B. H.; Carreira, E. M. Angew. Chem., Int. Ed. 2011, 50, 5379
12. Czekelius, C.; Carreira, E. M. Angew. Chem., Int. Ed. 2005, 44, 612
13. Diethelm, S.; Carreira, E. M. J. Am. Chem. Soc. 2013, 135, 8500
14. Myers, A. G.; Gin, D. Y.; Rogers, D. H. J. Am. Chem. Soc. 1993, 115, 2036
15. Myers, A. G.; Gin, D. Y.; Rogers, D. H. J. Am. Chem. Soc. 1994, 116, 4697
16. Prepared from the corresponding toluene in a radical bromination: Röhrig, S.; Jeske, M.; Perzborn, E.; Gnoth, M. J.; Prezborn, E. (Bayer Healthcare AG). US2010010060, 2010.
17. Muller, G. W.; Chen, R.; Huang, S. Y.; Corral, L. G.; Wong, L. M.; Patterson, R. T.; Chen, Y. X.; Kaplan, G.; Stirling, D. I. Bioorg. Med. Chem. Lett. 1999, 9, 1625
18. Muller, G. W.; Stirling, D. I.; Chen, R. S.-C. (Celgene Corp.). US 6335349, 2002.
19. Fujimoto, H.; Noguchi, T.; Kobayashi, H.; Miyachi, H.; Hashimoto, Y. Chem. Pharm. Bull. 2006, 54, 855
20. Wuitschik, G.; Rogers-Evans, M.; Buckl, A.; Bernasconi, M.; Märki, M.; Godel, T.; Fischer, H.; Wagner, B.; Parrilla, I.; Schuler, F.; Schneider, J.; Alker, A.; Schweizer, W. B.; Müller, K.; Carreira, E. M. Angew. Chem., Int. Ed. 2008, 47, 4512
21. Wuitschik, G.; Carreira, E. M.; Wagner, B.; Fischer, H.; Parrilla, I.; Schuler, F.; Rogers-Evans, M.; Müller, K. J. Med. Chem. 2010, 53, 3227
22. Burkhard, J. A.; Wuitschik, G.; Rogers-Evans, M.; Müller, K.; Carreira, E. M. Angew. Chem., Int. Ed. 2010, 49, 9052